Retinitis pigmentosa (RP) is a degenerative disease of retina which involves the pigment deposition in periphery of retina. In RP, there is degeneration of the rods and cones. So, RP is called as cone and rod dystrophy. Occurrence of RP is 1 in 4000 in human population. Major forms in which RP exist are simple, syndromic, non-syndromic.
Introduction
Eye is a complex organ of a human body. It makes human able to visualize different things with different colors.
Eye is composed of different layers i.e. cornea, lens, retina (it further contain rods and cones), optic nerve. The conversion of light signal to the visual signals, which are then transmitted to the brain is actually done by the retina.
Retina responds to light through sensory neuron and neural circuits. Retina layer contains two types of photoreceptor, 120 million rod and 1 million cones. Rod and cone are distinguished by their structure, types of photo-pigments, retinal distribution and pattern of synaptic connection as shown in Figure 1 . These properties show that cone and rod system is specialized for various aspects of vision. Rods have discs, similar to stacked coins. Rods function best in low light and cones in bright light of visible spectrum. Rods are more sensitive as compared to cones and they function in dim light. Fovea is a region present in the central segment of retina called as macula.
Fovea contains great number of cones photoreceptor density. 75% of the incident light reaches the fovea, it actually provokes greater degree of visual acuity. Inner region of the fovea contains 30 cones and it absorb one quarter of the photon. Rest of the photon is received by the cones of outer region of fovea. The probability of photon absorbed by a cone depends upon the following factors:
1. The direction of photon (most efficient direction of photon is along the axis of cone).
2. Frequency of approaching photon.
3. Types of cones (L, M, S type) [1] . 
Figure 2:
Eye affected by retinitis pigmentosa.
Symptoms
The symptoms of retinitis pigmentosa are night blindness in early stage, photophobia, patchy loss of peripheral vision, tunnel vision, and color perception impairment [2] .
Epidemiology
In early stage of the RP night blindness is the main symptoms that might appear in first year of life or in the second 
Mode of Inheritance
Inheritance of Retinitis pigmentosa from parents to their children is observed. Autosomal dominant are mildest forms starting after the age of 50 in some cases. During first decade of life autosomal recessive form starts. X-linked forms also start in early stage of RP and associate with myopia.
Syndromes Associated with Retinitis Pigmentosa
There are different syndromes associated with RP. Some of these syndromes are Pigment deposits in retina known as "bone spicules". in RP as compared to the untreated rats [5] .
Stem cells

It is a technique in which embryonic
Light protection
Patients suffering from RP should protect their eyes from ultraviolent rays and visible wavelength up to 527nm.
Protection of eyes can be done by using amber spectacles outdoor, which actually blocks the ultraviolent rays and light of approximately of wavelength 550 nm [5] .
Vitamin therapy
Vitamin A shows tropic and antioxidant effect so they may protect photoreceptors. Supplements of vitamin A ma reduce the degeneration of photoreceptors. Scientists found that in addition to vitamin A, DHA supplement at 1200mg/day is given to the RP patients as a result improvement was observed [6] .
RNA interference
RNA interference (RNAi) involve sequence-specific, post-transcriptionl silencing of gene initiated by double stranded RNA (dsRNA) that is complementary in sequence to the mRNA of the targeted gene. The principle of RNAi is that an enzyme called as dicer, which cuts the long dsRNA into short fragments. These small fragments are called as small interfering RNAs (siRNA). These 21-24 nucleotide duplexes enter in the so-called RNA-induced silencing complex (RISC) where the duplex is unwound. Argonaute protein actually degrades the one strand of dssRNA, leaving the remaining strand for binding to targeted mRNA sequence according to base pairing rule. A binds to T and G to C. Once siRNA binds to the targeted mRNA, argonaute protein then degrade the target RNA as shown in Figure 3 . Gene that encourage oxidative damage or apoptosis in retinal cells has been identified by RNAi [5] . 
Conclusion
Retina pigmentosa is an eye disorder, Different treatments strategies are being adopted to cure or to minimize the effect of disease.
